Skip to content
TheBrief.Health

Living with mucopolysaccharidosis type IIIA

Stories from people navigating mucopolysaccharidosis type IIIA — diagnosis, treatment, caregiving, and the ordinary days in between.

2 stories

Gene therapy infusion equipment beside a pediatric neurology referral file labeled Sanfilippo type A.

Neurology

Rebisufligene Opens a Pathway for Sanfilippo Type A

FDA approval establishes the first treatment pathway for pediatric Sanfilippo syndrome type A. Exact eligibility and monitoring should be confirmed against the prescribing information.

Rayan Salih · October 19, 2026 · 7 min

A pediatric developmental assessment kit beside genetic testing materials in a quiet neurology clinic.

Neurology

Sanfilippo Gene Therapy Hinges on Preserved Function

The first gene therapy for pediatric Sanfilippo syndrome type A is intended for children whose neurodevelopmental function remains preserved, making early assessment and referral central to eligibility.

Rayan Salih · 7 min read

Other conditions

One story a day

The story of the day, in your inbox

One health journey each morning — no advice, no alarm, just company for the road.